INTRODUCTION
Gonorrhea is the second most common sexually transmitted disease. The latest World Health Organization report estimates that 4100 million new gonococcal infections occur worldwide every year, 1 and the increasing resistance of Neisseria gonorrhoeae to even the latest generations of antibiotics is becoming problematic for effective treatment strategies. 2 Ascending gonococcal infections occur frequently, particularly in women, leading to fallopian tube scarring, pelvic inflammatory disease, infertility, and risk of ectopic pregnancy, which can be lifethreatening. 3 Epidemiological and clinical studies provide strong evidence that gonorrhea significantly increases the risk of acquisition and transmission of HIV. 1, 4 N. gonorrhoeae typically triggers an intense inflammatory response characterized by an influx of neutrophils into the genital tract, yet natural gonococcal infection does not induce a state of specific protective immunity. 5, 6 Individuals with gonorrhea are usually not protected from reinfection, although one study reported partial protection against the same serovar of N. gonorrhoeae. 7 This apparent lack of an adaptive immune response to N. gonorrhoeae probably contributes to the continuing prevalence of this sexually transmitted infection and challenges the development of a vaccine against it. The conventional working hypothesis holds that N. gonorrhoeae can evade host immune defenses by multifactorial strategies, including continuous changes in its surface antigenic structure, resistance to complement-mediated bacteriolysis, and possibly the production of immunoglobulin A1 (IgA1) protease. 5, [8] [9] [10] However, increasing evidence indicates that N. gonorrhoeae as a highly adapted pathogen has evolved specialized mechanisms to proactively suppress specific immune responses and promote growth and persistence in the host. For example, it has been demonstrated that N. gonorrhoeae opacity (Opa) proteins are able to bind carcinoembryonic antigen-related cellular adhesion molecule (CEACAM)-1 on activated human CD4 T cells and downregulate their activation and proliferation. 11 Recently, Zhu et al. 12 reported that N. gonorrhoeae could inhibit both human and mouse antigen-dependent CD4 T-cell proliferation through interactions with host antigen-presenting dendritic cells.
Although it has been recognized that N. gonorrhoeae possesses the capacity to modulate host immune responses, the underlying mechanisms remain to be elucidated. Furthermore, comprehension of how this can be manipulated to generate protective adaptive immunity against the organism is limited. Our previous studies in a mouse model of gonococcal infection have demonstrated that N. gonorrhoeae elicits T helper type 17 (Th17) responses, which are involved in the influx of neutrophils to the genital tract as well as the recruitment of other innate defense mechanisms. 13 By contrast, N. gonorrhoeae can selectively suppress Th1 and Th2 activity of mouse CD4 T cells, and induction of transforming growth factor-b (TGF-b) has a critical role in these differential effects.
14, 15 Blockade of TGF-b diverts the pattern of host immune responses to N. gonorrhoeae and enhances specific protective immunity against the pathogen. However, we found that complete inhibition of TGF-b activity only partially reverses N. gonorrhoeae-mediated suppression of Th1 and Th2 cell proliferation and typical cytokine production. 15 These results suggest that other unknown mechanisms also have an important role in the inhibitory effect of N. gonorrhoeae on Th1/Th2-mediated adaptive immune responses.
Interleukin (IL)-10 is a regulatory cytokine produced by a variety of immune cells, including activated T cells, monocytes/ macrophages, B cells, dendritic cells, and mast cells, 16 and it has a major role in suppressing immune and inflammatory responses and maintaining specific T-cell tolerance in both humans and mice. 17 Type 1 regulatory T (Tr1) cells are one type of induced regulatory T (Treg) cells, which inhibits Th1, Th2, and Th17 immunity through the production of immunosuppressive cytokines, mainly IL-10. 18 Tr1 cells arise in the periphery when naive CD4 þ T cells are activated by tolerogenic antigen-presenting cells (APC) in the presence of IL-10. 19 Therefore, the biological functions of IL-10 and Tr1 cells are closely related to each other. IL-10 is not only responsible for the regulatory effect of Tr1 cells but is also fundamental for their generation. Accumulating evidence indicates that IL-10 and Tr1 cells have a key role in regulating mucosal immune activation, for example, in the maintenance of gut immune homeostasis and tolerance to food antigens and enteric microbiota. 20, 21 In addition, IL-10 and Tr1 cells are exploited by many pathogens at mucosal sites to evade protective immunity, including Bordetella pertussis and Porphyromonas gingivalis. 22, 23 However, the potential role of IL-10 and Tr1 cells in genital tract infections has not been explored.
In this study, we show that, both in vitro and in vivo, N. gonorrhoeae strongly induced the production of IL-10 and Tr1 cells, which are critically involved in the suppression of adaptive immunity by the organism. Blockade of IL-10 and Tr1 cell activity significantly increased Th1, Th2, and Th17 responses to N. gonorrhoeae and resulted in the generation of immune memory in a mouse model of vaginal gonococcal infection. Furthermore, our results revealed that inhibition of IL-10 in combination with inhibition of TGF-b had an additive effect in promoting protective immunity against N. gonorrhoeae.
RESULTS

N. gonorrhoeae elicits abundant production of IL-10 and Tr1 cells in vitro
To determine whether N. gonorrhoeae is capable of inducing IL-10 and Tr1 cells, we incubated mouse iliac lymph node (ILN) cells with N. gonorrhoeae (FA1090) in serum-free medium for various time periods. After 4 days, mouse lymphocytes stimulated with N. gonorrhoeae produced extremely high levels of IL-10, but not of Th1-or Th2-type cytokines, such as IL-12p70 or IL-4 ( Figure 1a) . Flow cytometric analysis showed that IL-10 was produced in multiple immune cell types, To assess whether high level IL-10 production is a common phenomenon following bacterial challenge, we also incubated mouse lymphocytes with another Gram-negative bacterium, Escherichia coli, under the same conditions. E. coli induced much lower levels of IL-10 (Po0.001) but more IL-12p70 (Po0.001) and interferon (IFN)-g (Po0.01), as well as IL-4 and IL-2 ( Figure 1a ). All these data suggest that infection with different bacteria results in different immune responses characterized by the production of Th lineage-associated cytokines and show that N. gonorrhoeae potently elicits the immunosuppressive cytokine, IL-10.
As N. gonorrhoeae induced high levels of IL-10 in the absence of IL-4 and IL-2, we investigated whether it stimulated the generation of Tr1 cells. Flow cytometry studies revealed that most IL-10-producing CD4 þ T cells following gonococcal stimulation were IL-4 -and forkhead box p3 (Foxp3) - (Figure 1d ), which is consistent with a Tr1 cell classification. By contrast, N. gonorrhoeae did not significantly increase CD4 þ /Foxp3 þ Treg cells (Figure 1d) , and N. gonorrhoeae-induced Tr1 cells produced very low levels of TGF-b (Figure 1e) .
To examine the direct effect of N. gonorrhoeae on CD4 þ T cells, similar experiments were performed with purified CD4 (Figure 1g) , which suggests that IL-10 from other immune cell types contributes to the process.
To determine the production of cytokines in the mouse genital tract, vaginal explants were cultured with or without N. gonorrhoeae. Consistent with the above findings in lymphocyte cultures, IL-10 could be easily detected in the supernatants of vaginal explants stimulated with N. gonorrhoeae, whereas the production of other cytokines, including IL-12p70, IFN-g, and IL-4, was minimal (Figure 1h ).
N. gonorrhoeae induces IL-10 and Tr1 cells through multiple mechanisms
Our previous studies have demonstrated that gonococcal Opa proteins contribute to the induction of TGF-b and inhibition of Th1/Th2 responses by N. gonorrhoeae. 15 In vivo, Opa proteins have been shown to promote persistence of N. gonorrhoeae in the lower genital tract of infected mice. 24 We therefore investigated whether Opa proteins were involved in the elicitation of IL-10 and Tr1 cells in mouse lymphocytes by N. gonorrhoeae, using a mutant of N. gonorrhoeae (FA1090) in which all opa genes have been deleted. Previous colony dot-blot assays have shown that wild-type N. gonorrhoeae FA1090 expresses Opa A, B/D/G, and E/K, whereas the Opa-deficient mutant does not express any detectable Opa proteins. 15 We cultured ILN cells or purified CD4
þ T cells plus mitomycin C-inactivated APC with Opa-deficient or wild-type N. gonorrhoeae. In both whole lymphocyte and purified CD4 þ T-cell cultures, Opa-deficient N. gonorrhoeae induced significantly less IL-10 (Po0.05) and Tr1 cells (Po0.05) in comparison to the wild-type strain (Figure 2a,b) . However, the effect is modest, as in the absence of Opa expression N. gonorrhoeae still stimulated considerable levels of IL-10 and numbers of Tr1 cells, suggesting that other gonococcal factors and mechanisms also have an important role in this process.
Gonococcal lipooligosaccharide (LOS) is a critical virulence factor for N. gonorrhoeae and is a major inducer of the inflammatory cytokine response to the organism. 25, 26 We next determined whether generation of IL-10 and Tr1 cells was also dependent on LOS-TLR4 interactions. ILN lymphocytes or purified CD4
þ T cells plus inactivated APC from TLR4-normal C3H/FeJ or TLR4-deficient C3H/HeJ mice were stimulated with N. gonorrhoeae. Lack of TLR4 resulted in decreased IL-10 (Po0.001) and Tr1 cell (Po0.001) production in lymph node cell cultures (Figure 2c We have previously demonstrated that N. gonorrhoeae selectively suppressed the development of Th1 and Th2 cells. 15 As N. gonorrhoeae can induce abundant production of IL-10 and Tr1 cells, we determined whether these factors are critically involved in the inhibitory effect of N. gonorrhoeae on Th1 and Th2 responses. Purified mouse CD4 þ T cells were stimulated with anti-CD3 antibody under Th1-, Th2-, or Th17-polarizing conditions in the additional presence or absence of N. gonorrhoeae. IL-10 and Tr1 cell activities in the cultures were blocked by IL-10-neutralizing antibody at a dose determined to be effective without inducing toxicity. Flow cytometric analyses demonstrated that the addition of IL-10-neutralizing antibody significantly reversed N. gonorrhoeae-mediated suppression of Th1 and Th2 cell proliferation by 58.9 ± 7.2% (Po0.01) and 37.6 ± 5.3% (Po0.05), respectively ( Figure 3a) . Likewise, suppression of IFN-g production in Th1 cells and of IL-5 production in Th2 cells were significantly reversed by IL-10-neutralizing antibody by 62.8±6.5% (Po0.001) and 43.5±5.7% (Po0. Blockade of IL-10 and Tr1 cell activity enhances Th1/Th2 as well as Th17 immune responses to N. gonorrhoeae IL-10 and Tr1 cells strongly inhibit Th1 and Th2 immunity. Unlike TGF-b, IL-10 is not involved in the generation of Th17 cells, and increasing evidence indicates that IL-10 and Tr1 cells also downregulate Th17 immunity. 16, 19 We therefore 
IL-10 and Tr1 cell production in murine vaginal gonococcal infection
To determine whether N. gonorrhoeae induces IL-10 and Tr1 cells in vivo, we examined the local immune response in a mouse model of genital tract gonococcal infection. ILN and vaginas were removed from each of the five mice per group at 1, 3, 5, 7, and 14 days after inoculation with N. gonorrhoeae or vehicle only. Single-cell suspensions were prepared from each specimen for evaluation by flow cytometry to detect the expression of IL-10, IL-4, and Foxp3. Starting on day 3 after inoculation, IL-10 production was observed in various immune cells present in the ILN, including CD4
þ , and CD11c þ cells (Figure 4a ). IL-10 production peaked at day 5 and continued for the duration of infection. At day 5, 11.6-20.2% of the isolated immune cell types in the lymph nodes of infected mice were IL-10 þ , significantly higher than the levels in sham-infected controls (Figure 4a) . Almost all IL-10 þ /CD4 þ T cells were IL-4 -( Figure 4b ) and few were Foxp3 þ (Figure 4c) , a phenotype indicative of Tr1 cells. Similar results were observed in flow cytometric analysis of the infiltrating leukocytes in the vaginas (data not shown). The findings were further supported by quantitative RT-PCR analysis of mouse vaginal mRNA, which demonstrated that IL-10 was elevated by a factor of 10.4 ± 3.8 in N. gonorrhoeaeinfected mice relative to control mice (Po0.001). All these data indicated that N. gonorrhoeae elicits abundant production of IL-10 and Tr1 cells in vivo in a murine model of vaginal gonococcal infection.
ELISA analysis of vaginal wash, saliva, and serum of N. gonorrhoeae-infected and sham-infected mice showed a peak level of IL-10 (B60-90 pg ml infection and enhance bacterial clearance. To test this, groups of female BALB/c mice were vaginally infected with N. gonorrhoeae, and the bacterial burden was monitored daily by vaginal swab culture. The mice were injected with 300 mg of IL-10-neutralizing antibody or control IgG on days À 1 and 0 and every 2 days thereafter. Preliminary experiments showed this dose to be optimal without generating side-effects. The duration of gonococcal infection in control IgG-treated mice was B15 days (Figure 4d ). Anti-IL-10 treatment significantly reduced the recoverable gonococcal load starting from day 4, and led to faster clearance of the infection ( þ (Po0.05), and CD19 þ cell (Po0.01) influx into the genital tract (Figure 4g) . Consistent with the in vitro experiments, these in vivo findings revealed that inhibition of IL-10/Tr1 cell and TGFb activities had an additive effect in overcoming the suppression of Th1 and Th2 immunity by gonococci (Figure 4e,f) . Treatment of infected mice with both anti-IL-10 and anti-TGF-b further accelerated clearance of N. gonorrhoeae (F 1,238 ¼ 13.31; Po0.01; Figure 4d) .
To confirm the importance of IL-10 and Tr1 cells in the response to vaginal infection with N. gonorrhoeae, we repeated the experiment using IL-10 KO (C57BL/6 background) mice, which lack the capability to generate IL-10 and Tr1 cells. Gonococcal infection in wild-type C57BL/6 mice lasted about 2 weeks, whereas IL-10 KO mice started to show diminished gonococcal recovery from day 3 and had cleared the infection by day 7 (F 1,224 ¼ 61.74; Po0.001; Figure 4h ).
As IL-10 was produced by a variety of immune cell types in addition to Tr1 cells, we then investigated the specific role of Tr1 cells in an adoptive transfer experiment. IL-10-or N. gonorrhoeae-induced Tr1 cells were generated by prolonged culture of CD4 þ cells from BALB/c mice in the presence of IL-10 or N. gonorrhoeae, as described in Methods. Figure 4i) . However, the transfer of exogenous Tr1 cells did not prolong the duration of infection, possibly because large numbers of these cells were induced endogenously in the animals by infection with N. gonorrhoeae.
Groups of BALB
/c mice infected with N. gonorrhoeae were injected intravenously on days 0 and 3 with 1 Â 10 6 Tr1 or control CD4 þ T cells. Transfer of N. gonorrhoeae-induced (F 1,252 ¼ 64.03; Po0.01), but not IL-10-induced (F 1,252 ¼ 1.06; P ¼ 0.31), Tr1 cells elevated the recoverable gonococcal burdens in the treated mice from day 5 through 13 after inoculation (
Treatment with anti-IL-10 antibody protects mice against secondary N. gonorrhoeae infection
As inhibition of IL-10 and Tr1 cells elicited the development of Th1/Th2 adaptive responses to primary gonococcal infection, we then assessed whether the treatment resulted in the generation of immune memory and protective immunity. Reinfection studies were performed in which groups of mice treated with anti-IL-10 or control IgG during primary infection with N. gonorrhoeae were allowed to recover and then treated with ceftriaxone on day 15 to ensure complete clearance of the infection. An additional group of sham-infected mice treated with anti-IL-10 was used to evaluate the possible persistent effect of anti-IL-10 antibody in the absence of infection. Fiveto-six weeks later, all mice were inoculated with N. gonorrhoeae of the same strain without any further treatment. Consistent with previous studies, 14 the duration and bacterial burden of secondary infection in previously control IgG-treated mice were the same as for the primary infection of age-matched naive mice (F 1,294 ¼ 3.25; P ¼ 0.09; Figure 5a ). By contrast, anti-IL-10 treatment during primary N. gonorrhoeae infection protected the mice against secondary infection. Reinfected mice that had been treated with anti-IL-10 antibody during the primary infection recovered significantly faster than controls (F 1,294 ¼ 99.13; Po0.001; Figure 5a ). Interestingly, previous anti-IL-10 treatment of sham-infected mice did not induce protection against subsequent infection (F 1,294 ¼ 0.44; P ¼ 0.51; Figure 5a ). We also found that treatment with anti-IL-10 combined with anti-TGF-b during primary gonococcal infection protected the mice more effectively than treatment with anti-IL-10 alone (F 1,294 ¼ 10.68; Po0.05; Figure 5a) .
Flow cytometric and RT-PCR studies of ILN and vaginas taken on day 5 indicated that the protective effect of previous anti-IL-10 treatment on secondary gonococcal infection was also associated with enhanced Th1 (IFN-g; Po0.001) and Th2 (IL-4; Po0.01) responses (Figure 5b,c) . However, Th17 response (IL-17) in the reinfected mice with previous anti-IL-10 treatment was similar to those receiving control IgG treatment.
We then tested whether inhibition of IL-10 and Tr1 cells during N. gonorrhoeae infection led to the production of anti-gonococcal antibodies. IgM antibodies showed low levels and little difference between experimental groups (data not shown). No salivary gonococcus-specific antibody was detected in any group of mice (data not shown). Without anti-IL-10 treatment, neither primary nor secondary N. gonorrhoeae infection of mice induced the production of significant gonococcus-specific IgA or IgG antibody responses in either serum or vaginal wash (Figure 6a-d) . There was also no significant increase in specific IgA or IgG antibody responses in serum or vaginal wash to primary infection with anti-IL-10 treatment (Figure 6a,b) . However, there was a specific antibody response in anti-IL-10-treated mice after they were re-exposed to N. gonorrhoeae. Gonococcus-specific IgG antibodies in vaginal wash and serum of reinfected mice with previous anti-IL-10 treatment were significantly higher than those of controls (Po0.01; Figure 6c,d) . However, anti-IL-10 did not increase the production of specific IgA antibody in either serum or vaginal wash. Furthermore, we found that inhibition of both IL-10 and TGF-b during primary N. gonorrhoeae infection had an additive effect in enhancing the gonococcus-specific IgG antibody responses in both vaginal wash and serum to subsequent infection (Po0.05; Figure 6c ,d).
DISCUSSION
We have previously shown that vaginal infection of mice with N. gonorrhoeae selectively elicits IL-17-dependent innate responses and concomitantly suppresses Th1/Th2-driven adaptive immune responses through mechanisms that depend on TGF-b. [13] [14] [15] Administration of anti-TGF-b antibody alleviates this suppression and permits the development of Th1 and Th2 responses, as well as the establishment of immune memory and the generation of anti-gonococcal antibodies, thereby accelerating clearance of a primary gonococcal infection and protecting against a subsequent infection. 14, 15 The involvement of TGF-b in these effects suggests a role for Treg cells, which have been previously reported in the mouse model of genital gonococcal infection. 27 However, we noted that N. gonorrhoeae did not strongly induce expression of the nuclear transcription factor, Foxp3, that is associated with conventional induced Treg cell function. 15 We now show that N. gonorrhoeae induced very high levels of IL-10 and Tr1 cells both in cultured lymphoid cells in vitro and in cells recovered from mice vaginally infected with N. gonorrhoeae. As OT-II CD4 þ cells stimulated with N. gonorrhoeae or wild-type CD4 þ cells stimulated with N. gonorrhoeae in the absence of APC produced significantly less IL-10, it is likely that a significant proportion of N. gonorrhoeae-activated IL-10-producing CD4 þ cells are gonococcus-specific. The generation of IL-10 appeared to be a specific effect of N. gonorrhoeae, as culture of cells with another gram-negative bacterium, E. coli, induced much lower levels of IL-10 and much more IFN-g and IL-12. An Opa-deficient mutant of N. gonorrhoeae induced slightly lower levels of IL-10 in mouse cells in vitro, suggesting that other gonococcal components probably have an important role in this process. However, we could not determine whether a similar outcome occurs in vivo because this Opa-deficient mutant appears to have growth defects, which compromise its ability to infect mice. Moreover, it is unclear at present what receptors are engaged by gonococcal Opa proteins, as murine CEACAM receptors (unlike human CEACAMs) do not bind Opa. Unfractionated lymph node cells from TLR4-deficient mice were significantly less able to generate IL-10 in response to stimulation with N. gonorrhoeae, implying that gonococcal LOS contributes to this effect, but purified CD4 þ T cells (plus APC) did not replicate this effect, suggesting that LOS-responsive cells were not sufficiently represented in these cultures. Although TLR4 is expressed on myeloid cells, including APC, it is not present at high levels on murine T cells. We found previously that murine B cells, which are known to express TLR4, contribute to the LOS-stimulated generation of Th17 responses. 15 Others have found that TLR4-deficient mice infected with N. gonorrhoeae show higher peak bacterial loads and diminished Th17-related cytokine responses, but IL-10 was not examined. 25 However, as TLR4-deficiency impacts on many other aspects of the inflammatory response to infection in addition to IL-10 production, this outcome is not necessarily at variance with our findings.
Although many cell types secreted IL-10 in response to gonococcal stimulation, we found that the IL-10-producing CD4 þ T cells were mostly IL-4 -/Foxp3 -, a phenotype characteristic of Tr1 cells. 18 This subset of Treg cells is known to suppress Th1, Th2, and also Th17 cells. 16, 19, 28 Anti-IL-10 antibody reversed the suppression of Th1 and Th2 cells by N. gonorrhoeae without affecting the induction of Th17 cells. Anti-TGF-b antibody had an additive effect to anti-IL-10 on the reversal of Th1 and Th2 suppression, but it also counteracted the induction of Th17 cells, which require TGF-b for their generation.
These findings from in vitro experiments were reflected in the tissues of mice infected with N. gonorrhoeae in vivo. Thus lymphoid cells isolated from vaginal tissue and from the ILN, which drain the genital tract, of N. gonorrhoeae-infected mice showed production of IL-10 by CD4 þ and CD8 þ T cells, B cells, as well as both CD11b þ and CD11c þ cells, which are taken to be macrophages and dendritic cells, respectively. The selective induction of IL-10 in dendritic cells by N. gonorrhoeae has recently been reported. 12 Furthermore, the CD4 þ cells that produced IL-10 in vivo were largely IL-4 -and Foxp3 -, corresponding to the Tr1 phenotype. Accordingly, treatment of mice with blocking antibody to IL-10 during vaginal gonococcal infection accelerated the clearance of the infection and enhanced the generation of Th1 and Th2 cells without impairing the generation of Th17 cells. Co-administration of anti-TGF-b antibody with anti-IL-10 resulted in even faster clearance. In addition, IL-10-deficient mice were significantly more resistant to vaginal gonococcal infection than their wildtype counterparts. This phenotype is similar to that of IL-22-knockout mice, which are also resistant to vaginal gonococcal infection. 29 Beyond noting that IL-22 is structurally related to IL-10, shares the IL-10R2 signaling component in its receptor, and signals through Jak-STAT (janus kinase-signal transducer and activator of transcription) pathways, 17 we have no satisfactory explanation for the latter observation, as the two cytokines target different cells and have quite different biological effects.
To test directly the involvement of Tr1 cells in the suppression of immune responses by N. gonorrhoeae, we performed an adoptive transfer experiment. ILN cells from N. gonorrhoeae-infected mice were cultured for a prolonged period with gonococci of the same strain in the presence of anti-CD3 antibodies, which led to the generation of gonococcusspecific Tr1 cells. Adoptive transfer of these cells into congenic mice that were infected with N. gonorrhoeae impaired early reduction of the bacterial load. Non-specific Tr1 cells generated by culture with IL-10 did not have this effect. However, transfer of gonococcus-specific Tr1 cells did not prolong the total course of infection, and we ascribe that to the endogenous generation of Tr1 cells as a consequence of infection. In these circumstances, it seems likely that the adoptive transfer of additional, exogenously generated Tr1 cells served to suppress the early response but did not alter the ultimate outcome.
We previously demonstrated that treatment of mice with blocking antibodies to TGF-b during primary gonococcal infection leads to the establishment of Th1-and Th2-driven immune memory that can be recalled upon subsequent reinfection with N. gonorrhoeae.
14 As a result, the second infection is cleared more effectively, and anti-gonococcal IgA and IgG antibodies are found in the serum and genital secretions-neither of which outcomes occurs normally in reinfected mice. 14, 30 We found similar development of protective anamnestic immune responses, including antigonococcal IgG antibodies, when mice that were treated with anti-IL-10 antibody during primary infection were challenged a second time but without further treatment with anti-IL-10 antibody. Moreover, treatment with anti-TGF-b in addition to anti-IL-10 antibody increased the effect. Similar to blockade of TGF-b, which promotes both Th1 and Th2 anamnestic responses, 14 blockade of IL-10 enhanced Th1 and Th2 responses measured by the expression and production of IFN-g and IL-4 in the genital tract tissues and draining ILN. However, in contrast to anti-TGF-b, which facilitates the generation of both IgG and IgA anti-gonococcal antibody responses, 14 anti-IL-10 treatment enhanced only IgG antibody responses in serum and vaginal secretion, and unlike anti-TGF-b, it did not inhibit the IL-17 response.
From these findings and our previous studies, we conclude that N. gonorrhoeae suppresses Th1-and Th2-driven adaptive immune responses against itself by mechanisms that depend upon TGF-b and IL-10 and that involve the generation of Tr1 cells, which are known to inhibit Th1 and Th2 cells. This induced, specific immunosuppression can be reversed by blockade of IL-10 and/or TGF-b, thereby allowing the induction of Th1 and Th2 cells, the establishment of immune memory, the generation of specific anti-gonococcal antibodies, and the development of protective immunity. This has not previously been accomplished in models of genital tract infection with N. gonorrhoeae.
We have proposed that the suppression of Th1-and Th2-driven specific immune responses coupled with the selective elicitation of Th17-dependent innate immune responses is an adaptive strategy that enables N. gonorrhoeae to colonize its host by proactively directing the pattern of host immune responses in its own favor. 31 N. gonorrhoeae appears well able to resist innate defense mechanisms driven by Th17 responses, as it can survive within neutrophils 32, 33 and resist antibacterial proteins such as defensins by means of a multi-drug exporter mechanism. 34 Under this hypothesis, we propose that Th1/ Th2-driven adaptive immune responses, such as the generation of specific anti-gonococcal antibodies, provide the key additional factor that arms host defenses effectively against N. gonorrhoeae. It is unclear, at present, whether Th17-driven responses, such as the neutrophil influx, are essential for clearance of vaginal gonococcal infection in mice. IL-17 receptor A-knockout mice, or normal mice treated with IL-17-blocking antibody, show prolonged infection and diminished neutrophil influx into the genital tract. 13 However, the association of these two effects may be coincidental, because the neutrophil influx varies between different strains of mice regardless of the clearance kinetics. 35 Moreover, in our studies of murine vaginal gonococcal infection, clearance still occurred in IL-17 receptor A-knockout mice despite the absence of a neutrophil influx. 13 It is likely that numerous factors are responsible for the elimination of vaginal gonococcal infection in mice, including not only host responses to the infection but also the fact that N. gonorrhoeae is an exclusively human pathogen that has become evolutionarily well adapted to its sole natural host and is not ordinarily capable of infecting mice. However, it is possible that these effects are limited to the artificial murine infection, and therefore it is critical to determine the extent to which they apply to the natural human infection. It has already been reported that humans infected with gonorrhea have elevated serum IL-17 and IL-23, 36 but it is not clear whether this is a consequence of infection or a predisposing factor in acquiring the infection.
The preponderance of clinical experience shows that episodes of gonorrhea do not induce effective immunity against re-infection, as gonorrhea can be re-acquired with no apparent reduction in severity or duration of disease. The conventional explanations adduced for this situation include the extraordinary capacity of N. gonorrhoeae for antigenic variation involving most of its surface antigens, 5 coupled with numerous mechanisms for inhibiting complement activation and resisting cytolysis. 10 It is also becoming clear that N. gonorrhoeae can survive phagocytosis by neutrophils, the predominant cells found in the exudates that are characteristic of symptomatic gonorrhea, by interfering with both oxygendependent and oxygen-independent intracellular killing. 32, 33 Although all of these mechanisms undoubtedly contribute to the success of N. gonorrhoeae as a pathogen, we propose that it also suppresses specific adaptive immune responses, including antibody development, that might be capable of eliminating it. Our findings reported here and previously support this concept and indicate some of the mechanisms whereby this is achieved.
Our findings are complemented by a recent report that N. gonorrhoeae interacts with dendritic cells to induce the production of not only IL-10 but also programmed death ligand 1.
12 As a result, such gonococcus-exposed dendritic cells suppress antigen-induced proliferation of CD4 þ T cells. It had previously been shown that N. gonorrhoeae can inhibit the proliferation of human CD4 þ T cells through the binding of gonococcal Opa proteins to it receptor, CEACAM-1, which is expressed on these cells. 11 A similar effect on human B cells was also reported. 37 Thus it appears that N. gonorrhoeae can interact with host immune cells at multiple levels, i.e., with APC, Th cells, and B cells, as well as Tr1 cells, to suppress the development of specific immune responses. We propose that if specific immune responses to N. gonorrhoeae were allowed to proceed in the normal manner, then the effector products of such immune activation, particularly including anti-gonococcal antibodies, might be able to eliminate the infection. Moreover, the concomitant establishment of immune memory might provide protection against re-infection, assuming a sufficient degree of antigenic similarity between the original and new infecting strains. Possibly this occurs eventually in natural human infections if they are allowed to proceed untreated, and anecdotal evidence from the pre-antibiotic era suggests that gonorrhea is ultimately self-limiting. 38 However, it is completely unethical to test such speculations directly in humans. Instead, our evidence from experimental murine infections indicates that it is possible to immunologically reverse the natural capacity of N. gonorrhoeae to suppress Th1-and Th2-mediated specific immune responses against it and allow the development of protective immune responses that not only accelerate clearance of an existing infection (therapy) but also generate protection against future infection (prophylaxis). In our experiments so far, these include the systemic administration of blocking antibodies against TGF-b and IL-10. Ongoing studies are aimed at determining whether these approaches can be developed into more practical interventions against genital tract infection with N. gonorrhoeae.
METHODS
Mice. All mice, including wild-type BALB/c and C57BL/6 mice, C3H/ HeJ (TLR4-deficient), C3H/FeJ (TLR4-normal), B6.129P2-Il10tm1Cgn/J (IL-10 KO ), and B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II) mice on a C57BL/6 background, were purchased from Jackson Laboratories (Bar Harbor, ME). BALB/c mice were used for the experiments unless otherwise specified. Mice were maintained under standard conditions in the Laboratory Animal Facility at the University at Buffalo, Buffalo, NY, which is fully accredited by AAALAC. All animal use protocols were approved by the Institutional Animal Care and Use Committee of the University at Buffalo, Buffalo, NY.
Bacteria. N. gonorrhoeae FA1090 and an Opa-deletion mutant of FA1090 were kindly provided by Dr Janne Cannon (University of North Carolina at Chapel Hill). Bacteria were cultured on GC agar supplemented with hemoglobin and Isovitalex (BD Diagnostic Systems, Franklin Lakes, NJ) and the resultant growth was checked for colony morphology consistent with Opa protein and pilus expression. Bacteria were harvested from plates, and the cell density was determined as detailed previously.
14 Mouse vaginal infection model. Female mice between 7 and 9 weeks old were infected with live N. gonorrhoeae FA1090 as previously described, 14, 39 with the modification that water-soluble estradiol was administered on days À 2, 0, and 2. Vaginal mucus was quantitatively cultured daily on GC agar supplemented with selective antibiotics to determine the bacterial colonization loads. In some experiments, mice were injected subcutaneously on days À 1, 0, and every 2 days thereafter, with 300 mg IL-10 or/and TGF-b-neutralizing monoclonal antibodies (mAb) or control mouse IgG purchased from Bio X Cell (West Lebanon, NH).
Lymphocyte isolation and culture. Mononuclear cells were isolated from aseptically harvested ILN using Histopaque 1083 (SigmaAldrich, St Louis, MO) density-gradient centrifugation. CD4 þ T cells were purified by magnetic-activated cell sorting (MACS) through negative selection using a Dynal CD4 cell isolation kit (Invitrogen, Carlsbad, CA). Cells were cultured in 24-well culture plates at a density of 1 Â 10 6 cells ml À 1 with either no stimulus or N. gonorrhoeae cells at indicated MOI. For some purified CD4 þ T-cell cultures, equal numbers of APC (mitomycin C-inactivated splenocytes) were added. X-VIVO serum-free medium (Lonza, Walkersville, MD) with penicillin/streptomycin was used for all experiments. For some experiments, 40 mg ml À 1 mouse IL-10 and/or TGF-b neutralizing mAb (Bio X Cell) was added.
Th cell differentiation. Naive purified CD4 þ T cells (1 Â 10 6 cells ml À 1 ) were cultured in 24-well tissue culture plates and stimulated with 1.0 mg ml À 1 plate-bound anti-CD3 antibody (eBiosciences, San Diego, CA) in complete X-VIVO medium. Differentiation of Th1, Th2, and Th17 cells was induced by the addition of IL-12 and anti-IL-4 antibody, IL-4 and anti-IFN-g antibody, or TGF-b and IL-23 plus anti-IFN-g and anti-IL-4 antibodies, respectively, as detailed previously. 15 In each condition, the cells were cultured in the absence or presence of N. gonorrhoeae FA1090 (MOI 50:1) and mitomycin C-inactivated APCs for 4 days. Supernatants and cells were then collected for ELISA and flow cytometry analyses. In some experiments, 40 mg ml À 1 anti-IL-10 and/or anti-TGF-b mAb was added as indicated.
Vaginal explant culture and cell isolation. Genital tracts were dissected out aseptically and washed with Hanks's buffered salt solution. The tissue was manually separated into about 1 mm pieces, washed again, and weighed. Equal weights were added to each well of 24-well cell culture plates. Tissue was incubated in X-VIVO serum-free medium supplemented with penicillin, streptomycin, and fungizone. Vaginal single-cell suspensions were prepared by protease digestion of excised vaginal tissue, as described previously. 14 In vitro Tr1 cell induction. For generation of IL-10-induced Tr1 cells, CD4 þ /CD62L þ T cells were isolated from naive BALB/c mouse ILN by fluorescence-activated cell sorter (FACSAria; Becton-Dickinson, Franklin Lakes, NJ). The sorted cells were cultured and stimulated repeatedly for 3 weeks with anti-CD3 antibody (eBiosciences) in the presence or absence (control) of IL-10 (10 ng ml À 1 ). Medium with antibodies, cytokines, and stimulants was changed twice a week, and IL-2 (50 units ml À 1 ) was added to the cultures after 2 weeks. For generation of N. gonorrhoeae-induced Tr1 cells, ILN cells obtained from N. gonorrhoeae-infected mice were similarly stimulated for 3 weeks with anti-CD3 in the presence of N. gonorrhoeae. At the end of stimulation, CD4 þ cells were purified by MACS for adoptive transfer.
Cytokine ELISA. IL-10, TGF-b, IFN-g, IL-12p70, IL-4, IL-5, and IL-17A levels were measured in triplicate using ELISA kits purchased from eBioscience.
Flow cytometry. Cells were washed with staining buffer twice, then incubated with the indicated antibodies for 30 min on ice, washed twice, and analyzed on a FACSCalibur cytometer (Becton-Dickinson).
For intracellular staining, cells were first fixed with Cytofix/Cytoperm (eBioscience). Antibodies to mouse CD4, CD8, CD19, CD11b, CD11c, NKG2D, Gr-1, IFN-g, IL-4, IL-17A, and Foxp3 conjugated with fluorescein isothiocyanate, phycoerythrin, or allophycocyanin were purchased from eBioscience. PE-conjugated anti-TGF-b antibody was obtained from IQ Products (Groningen, The Netherlands).
Proliferation assays. Cells were labeled with carboxymethyl fluorescein succinimide ester (CFSE; Sigma-Aldrich) according to a previous protocol. 40 CFSE-labeled cells were then washed twice in phosphate-buffered saline, recounted, and stimulated as described above. Cultured cells were harvested and then stained with allophycocyanin-conjugated anti-mouse CD4 antibody. The data were acquired by gating on the CD4 þ cell populations in a FACSCalibur cytometer. The sequential loss of CFSE fluorescence was used to measure cell proliferation.
Real-time RT-PCR. Total cellular RNA of MACS-purified, cultured CD4 þ T cells or whole vaginas harvested from the mice was isolated with RNeasy Mini Kits (Qiagen, Valencia, CA) and was transcribed to cDNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Real-time RT-PCR was performed on an iCycler iQ detection system (Bio-Rad) using Sybergreen (Bio-Rad) for real-time monitoring of the PCR. The primers used were as follows: T-bet, 5
0 -GGAGCGGACCA ACAGCATCG-3 0 ; 5 0 -GCGGGCGGCGGGAAGAACT-3 0 ; GATA3, 0 . Relative quantification of target genes was analyzed based on the threshold cycle (Ct) determined by Bio-Rad iQ5 optical system software.
Assay of serum and mucosal antibodies. Samples of saliva, vaginal wash, and serum were collected from individual mice on day 15 post inoculation.
14 Gonococcus-specific IgA, IgG, and IgM in saliva, sera, and vaginal washes were measured by ELISA on plates coated with whole gonococci (FA1090). Total IgA, IgG, and IgM concentrations in secretions were assayed by ELISA on plates coated with anti-IgA, -IgG, or -IgM antibodies (Southern Biotech, Birmingham, AL). H5 mouse monoclonal antibody (specific for FA1090 porin; kindly provided by Ann E. Jerse, Uniformed Services University of the Health Sciences) or affinity-purified mouse IgA, IgG, and IgM (Southern Biotech) were used to establish standard curves. Bound antibodies were detected by alkaline phosphatase-conjugated goat anti-mouse IgA, IgG, or IgM antibody (Southern Biotech) and p-nitrophenylphosphate substrate (Southern Biotech). Plates were read in a VersaMax microplate reader (Molecular Devices, Sunnyvale, CA), and calibration curves for interpolation of unknowns were constructed using SoftMax software (Molecular Devices).
Statistical analysis. Data are expressed as the means±s.e.ms. Data on the effect of anti-IL-10 or/and anti-TGF-b vs. control IgG treatments on mouse vaginal N. gonorrhoeae infection were analyzed using twoway analysis of variance with Fisher's protected least significant difference post hoc tests for multiple comparisons. Unpaired two-tailed t tests were used to compare the mean values between two groups. Po0.05 was considered statistically significant.
